Octagon Capital Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.99M | Sell |
148,000
-148,000
| -50% | -$6.99M | 1.53% | 23 |
|
|
2025
Q1 | $11.6M | Buy |
+296,000
| New | +$11.6M | 2.24% | 18 |
|
|
2022
Q1 | – | Sell |
-400,000
| Closed | -$3.96M | – | 29 |
|
|
2021
Q4 | $3.96M | Hold |
400,000
| – | – | 0.77% | 21 |
|
|
2021
Q3 | $3.95M | Hold |
400,000
| – | – | 0.97% | 23 |
|
|
2021
Q2 | $4.13M | Hold |
400,000
| – | – | 0.86% | 29 |
|
|
2021
Q1 | $4.08M | Hold |
400,000
| – | – | 1.54% | 24 |
|
|
2020
Q4 | $4.55M | Buy |
+400,000
| New | +$4.55M | 1.58% | 22 |
|